Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Savita Gossain"'
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0169332 (2016)
Faster identification of bacterial isolates from blood cultures can enable earlier clinical intervention for patients with sepsis. We evaluated the clinical impact of direct identification of micro-organisms from positive blood cultures using MALDI-T
Externí odkaz:
https://doaj.org/article/40358c924b3e48e394e27606680742f1
Autor:
Bridget Hilton, Obaghe Edeghere, Savita Gossain, Neville Q. Verlander, Susan Hopkins, Dean Ironmonger, Peter M Hawkey
Publikováno v:
The Journal of antimicrobial chemotherapy. 73(3)
Objectives To assess the effect of general practice characteristics and antibiotic prescribing on the number of non-susceptible Escherichia coli isolated from urine specimens submitted from community settings, we undertook an ecological study of the
Autor:
Edward F. Nash, R. Rashid, E. Justice, Savita Gossain, R.G. Edgar, K.J. Hardy, Joanna L. Whitehouse
Publikováno v:
Journal of Cystic Fibrosis. 18:S86
Autor:
Thomas P. Hellyer, Niall H. Anderson, Jennie Parker, Paul Dark, Tina Van Den Broeck, Suveer Singh, Ronan McMullan, Ashley M. Agus, Lydia M. Emerson, Bronagh Blackwood, Savita Gossain, Tim S. Walsh, Gavin D. Perkins, Andrew Conway Morris, Daniel F. McAuley, A. John Simpson
Publikováno v:
Hellyer, T P, Anderson, N H, Parker, J, Dark, P, Van Den Broeck, T, Singh, S, McMullan, R, Agus, A M, Emerson, L M, Blackwood, B, Gossain, S, Walsh, T S, Perkins, G D, Morris, A C, McAuley, D F & Simpson, A J 2016, ' Erratum to: 'Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial' ', Trials, vol. 17, no. 1, 465, pp. 1 . https://doi.org/10.1186/s13063-016-1594-8
Trials
Trials
Background Ventilator-acquired pneumonia (VAP) is a common reason for antimicrobial therapy in the intensive care unit (ICU). Biomarker-based diagnostics could improve antimicrobial stewardship through rapid exclusion of VAP. Bronchoalveloar lavage (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59ffdec3e180ea0756b4440785f79dc5
https://doi.org/10.1186/s13063-016-1594-8
https://doi.org/10.1186/s13063-016-1594-8
Autor:
Suveer Singh, Jennie Parker, Niall Anderson, Ashley Agus, Timothy S. Walsh, Gavin D. Perkins, Savita Gossain, Andrew Conway Morris, Lydia M Emerson, A. John Simpson, Thomas P Hellyer, Paul Dark, Tina Van Den Broeck, Bronagh Blackwood, Ronan McMullan, Daniel F. McAuley
Publikováno v:
Trials
Hellyer, T P, Anderson, N H, Parker, J, Dark, P, Van Den Broeck, T, Singh, S, McMullan, R, Agus, A M, Emerson, L M, Blackwood, B, Gossain, S, Walsh, T S, Perkins, G D, Conway Morris, A, McAuley, D F & Simpson, A J 2016, ' Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2) : Study protocol for a randomised controlled trial ', Trials, vol. 17, no. 1, 318, pp. 318 . https://doi.org/10.1186/s13063-016-1442-x, https://doi.org/10.1186/s13063-016-1442-x
Hellyer, T P, Anderson, N H, Parker, J, Dark, P, Van Den Broeck, T, Singh, S, McMullan, R, Agus, A M, Emerson, L M, Blackwood, B, Gossain, S, Walsh, T S, Perkins, G D, Conway Morris, A, McAuley, D F & Simpson, A J 2016, ' Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2) : study protocol for a randomised controlled trial ', Trials, vol. 17, no. 1, pp. 318 . https://doi.org/10.1186/s13063-016-1442-x
Hellyer, T P, Anderson, N H, Parker, J, Dark, P, Van Den Broeck, T, Singh, S, McMullan, R, Agus, A M, Emerson, L M, Blackwood, B, Gossain, S, Walsh, T S, Perkins, G D, Conway Morris, A, McAuley, D F & Simpson, A J 2016, ' Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2) : Study protocol for a randomised controlled trial ', Trials, vol. 17, no. 1, 318, pp. 318 . https://doi.org/10.1186/s13063-016-1442-x, https://doi.org/10.1186/s13063-016-1442-x
Hellyer, T P, Anderson, N H, Parker, J, Dark, P, Van Den Broeck, T, Singh, S, McMullan, R, Agus, A M, Emerson, L M, Blackwood, B, Gossain, S, Walsh, T S, Perkins, G D, Conway Morris, A, McAuley, D F & Simpson, A J 2016, ' Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2) : study protocol for a randomised controlled trial ', Trials, vol. 17, no. 1, pp. 318 . https://doi.org/10.1186/s13063-016-1442-x
Ventilator-acquired pneumonia (VAP) is a common reason for antimicrobial therapy in the intensive care unit (ICU). Biomarker-based diagnostics could improve antimicrobial stewardship through rapid exclusion of VAP. Bronchoalveloar lavage (BAL) fluid
Autor:
Vicki Chalker, Georgia Kapatai, Juliana Coelho, Mamoona Tahir, Savita Gossain, Huda Mohamed, Katherine Martin
Publikováno v:
Open Forum Infectious Diseases. 3
Autor:
Helen Parsons, Claire Waddington, Susan Manzoor, Ala Szczepura, Claire Marriott, Savita Gossain, Nigel Stallard, Katherine J. Hardy, Peter M. Hawkey
Publikováno v:
Journal of Clinical Microbiology. 50:3244-3248
The early identification of outbreaks is crucial for the control of Clostridium difficile infection. This study aimed to determine if the number of hospital-acquired C. difficile infections could be reduced by rapidly typing C. difficile strains usin
Publikováno v:
Journal of Hospital Infection. 75:277-281
In recent years the rates of Clostridium difficile infection (CDI) have increased worldwide with several large outbreaks occurring within the UK. New guidance from the UK Department of Health describes measures to investigate periods of increased inc
Autor:
Katherine J. Hardy, Claire McMurray, Savita Gossain, Ala Szczepura, Ruth Davies, Nigel Stallard, Peter M Hawkey, Andrew W. Bradbury, Charlotte L Price, Sahida Shabir
Publikováno v:
Clinical Microbiology and Infection. 16(4):333-339
Identification of patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) and subsequent isolation and decolonization is pivotal to the control of cross infection in hospitals. The aim of this study was to establish if early identi
Autor:
Niall Anderson, Ian Dimmick, Suveer Singh, Simon Baudouin, Stephen E Wright, Emma Browne, Daniel F. McAuley, Thomas P Hellyer, Nicole M Robin, John Widdrington, I. F. Laurenson, Andrew Conway Morris, Craig Spencer, Shondipon Laha, Timothy S. Walsh, Frans Nauwelaers, A. John Simpson, Jonathan Scott, Savita Gossain, Sarah Wiscombe, Gavin D. Perkins, Melinda Jeffels, Cecilia O'Kane, Kate Gould, Paul Dark, James G. Macfarlane, Alistair I Roy, Ronan McMullan, Marie-Hélène Ruchaud-Sparagano, Kallirroi Kefala
Publikováno v:
Hellyer, T P, Conway Morris, A, McAuley, D F, Walsh, T S, Anderson, N H, Singh, S, Dark, P, Roy, A I, Baudouin, S V, Wright, S E, Perkins, G D, Kefala, K, Jeffels, M, McMullan, R, O'Kane, C M, Spencer, C, Laha, S, Robin, N, Gossain, S, Gould, K, Ruchaud-Sparagano, M-H, Scott, J, Browne, E M, MacFarlane, J G, Wiscombe, S, Widdrington, J D, Dimmick, I, Laurenson, I F, Nauwelaers, F & Simpson, A J 2015, ' Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia ', Thorax, vol. 70, no. 1, pp. 41-47 . https://doi.org/10.1136/thoraxjnl-2014-205766
Background: Excessive use of empirical antibiotics is common in critically ill patients. Rapid biomarker-based exclusion of infection may improve antibiotic stewardship in ventilator-acquired pneumonia (VAP). However, successful validation of the use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a110c92adc8abf9c19a9489bae9d28b
https://www.repository.cam.ac.uk/handle/1810/307336
https://www.repository.cam.ac.uk/handle/1810/307336